# Diagnostic Performance of a Novel Lipoarabinomannan.

> **NCT05036694** · NA · UNKNOWN · sponsor: **Médecins Sans Frontières, Kenya** · enrollment: 550 (estimated)

## Conditions studied

- HIV Primary Infection

## Interventions

- **DEVICE:** FUJILAM KIT

## Key facts

- **NCT ID:** NCT05036694
- **Lead sponsor:** Médecins Sans Frontières, Kenya
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09
- **Primary completion:** 2022-09
- **Final completion:** 2022-12
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2021-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05036694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05036694, "Diagnostic Performance of a Novel Lipoarabinomannan.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05036694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*